Depression and memory declines may be closely linked in older people, new research suggests. “Our study shows that the relationship between depression and poor memory cuts both ways, with depressive symptoms preceding memory decline and memory decline...

Older women with chronic kidney disease might wind up losing so many teeth they aren’t able to chew and talk effectively, a new study warns. Postmenopausal women with kidney disease are about 40% more likely to have...

Folks trying to control their blood sugar levels might do best to work out in the evening, a new study suggests. Exercise performed between 6 p.m. and midnight appeared to be better at controlling blood sugar levels...

Mankind is eyeing Mars as its next grand expedition, but the human body might not be capable of dealing with such a journey, a new study warns. It’s very likely that an astronaut’s kidneys could be permanently...

It’s tempting to binge-watch TV, but yet another study finds that when it comes to healthy aging, the less time on your sofa, the better. The study looked at 20 years of data on more than 45,000...

A new proposed definition for Long COVID could help patients get the help they need, a new report from the National Academies of Sciences, Engineering and Medicine says. Long COVID is a chronic condition that occurs after...

Astronauts orbiting the Earth tend to suffer from immune system problems such as infections and the reactivation of dormant viruses, even on short-term space flights. That appears to be because a lack of gravity causes the immune...

A test used to gauge whether a college athlete has suffered a concussion is right only half the time and may be useless, new research finds. The test used by the NCAA, which oversees college sports, measures...

The first all-civilian space mission is shedding light on the potential health risks facing private astronauts. The takeaway: Short-duration spaceflights appear to pose none that are significant. The study sample was small — four people who spent...

A U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and bleeding. Eli Lilly’s donanemab did...